Table 2.
Univariate competing risk Cox regression models identifying predictors for non-death-related drop out
| “drop out” assuming "death" as a competing risk | |||
|---|---|---|---|
| Hazard Ratio | 95% Confidence Interval | P value | |
| Age in years | 1.02 | 0.98–1.06 | .37 |
| Sex | |||
| male | 1.91 | 0.72–5.08 | .20 |
| female | 1.00 | ||
| Living situation | |||
| in relationship | 0.44 | 0.17–1.16 | .10 |
| single | 1.00 | ||
| WHO grade | |||
| LGG (WHO I and II) | 1.50 | 0.56–4.00 | .42 |
| HGG (WHO III and IV) | 1.00 | ||
| Eloquent tumor location | |||
| yes | 1.18 | 0.46–2.98 | .73 |
| no | 1 | ||
| Ongoing chemotherapy | |||
| yes | 2.40 | 0.95–6.08 | .07 |
| no | 1 | ||
| Surgery for recurrent tumor | |||
| yes | 1.19 | 0.43–3.34 | .74 |
| no | 1 | ||
| Karnofsky Index in percent | 0.99 | 0.96–1.03 | .71 |
| Time since diagnosis in years | 1.00 | 1.00–1.00 | .83 |
| Value on Distress Thermometer | |||
| ≥ 6 | 1.04 | 0.39–2.77 | .94 |
| < 6 | 1 | ||
| Selected EORTC-QLQ-C30 and EORTC-QLQ-BN20 scales | |||
| C30 Global Health Status/QoL | 1.00 | 0.97–1.01 | .42 |
| C30 Physical functioning | 0.99 | 0.97–1.00 | .20 |
| C30 Emotional functioning | 1.00 | 0.98–1.02 | .96 |
| C30 Cognitive functioning | 1.00 | 0.99–1.02 | .74 |
| BN20 Future uncertainty | 1.01 | 1.00–1.03 | .17 |
| BN20 Motor dysfunction | 1.02 | 1.00–1.03 | .03 |
| SCNS-SF34G scores | |||
| Physical and daily living needs | 1.00 | 0.98–1.02 | .91 |
| Psychological needs | 1.00 | 0.98–1.02 | .87 |
| Patient care and support needs | 1.01 | 0.99–1.03 | .45 |
| Health system and information needs | 1.01 | 0.99–1.02 | .22 |
| Sexuality needs | 1.00 | 0.96–1.02 | .41 |
HGG, high-grade glioma; LGG, low-grade glioma